NCT06531993View on ClinicalTrials.gov

Effect of Pectin in Chronic Kidney Disease Patients ( Stage 3 and 4 )

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

August 31, 2025

Conditions
Chronic Kidney Diseases
Interventions
DRUG

Pectin

Using pectin as tablets 600 mg per day for 6 months

All Listed Sponsors
lead

Assiut University

OTHER

NCT06531993 - Effect of Pectin in Chronic Kidney Disease Patients ( Stage 3 and 4 ) | Biotech Hunter | Biotech Hunter